Brookfield vs CME Group

Brookfield and CME Group are compared on this page, examining their business models, financial performance, and market context in a neutral, accessible way. The overview highlights operating structures, revenue considerations, and competitive positioning to help readers understand differences and similarities. Educational content, not financial advice.

Brookfield and CME Group are compared on this page, examining their business models, financial performance, and market context in a neutral, accessible way. The overview highlights operating structure...

Comparison Snapshot

Key Financial Metrics

BN

Metric

CME

$117.08B

Market Cap

$109.29B

9.29%

Potential Profit

-6.15%

Buy

Analyst Rating

Hold

Why It's Moving

Brookfield Shares Jump 2.8% as Earnings Beat Expectations with Dividend Hike and Massive Buyback.

Robust annual earnings triggered a post-report rally, fitting BN's historical 2.6% average earnings-day move while exceeding trader expectations.
Dividend soared 17%, underscoring the company's commitment to boosting shareholder returns in a competitive landscape.
Over $1 billion in share repurchases highlights strong capital deployment, with options activity spiking on $50 calls for potential upside.

Sentiment:

🐃Bullish

CME Stock Warning Overstated: Record Highs and Earnings Beats Counter Analyst Downside Fears

Q4 revenue hit $1.65B, topping $1.64B forecasts by 8.1% year-over-year, driven by record volumes in metals, Bitcoin futures, and S&P 500 E-mini contracts that underscore CME's grip on high-volatility trading.
Earnings per share reached $2.77 versus $2.75 expected, with management spotlighting new 'event contracts' and booming retail sales in micro products to diversify revenue streams.
Announced $6.15 annual variable dividend plus $1.30 Q1 payout—totaling ~$4B for 2025 at 4.2% yield—while planning summer launch of single-stock futures on top names like NVIDIA and Tesla for capital-efficient exposure.

Sentiment:

🐃Bullish

Brookfield Shares Jump 2.8% as Earnings Beat Expectations with Dividend Hike and Massive Buyback.

Robust annual earnings triggered a post-report rally, fitting BN's historical 2.6% average earnings-day move while exceeding trader expectations.
Dividend soared 17%, underscoring the company's commitment to boosting shareholder returns in a competitive landscape.
Over $1 billion in share repurchases highlights strong capital deployment, with options activity spiking on $50 calls for potential upside.

Sentiment:

🐃Bullish

CME Stock Warning Overstated: Record Highs and Earnings Beats Counter Analyst Downside Fears

Q4 revenue hit $1.65B, topping $1.64B forecasts by 8.1% year-over-year, driven by record volumes in metals, Bitcoin futures, and S&P 500 E-mini contracts that underscore CME's grip on high-volatility trading.
Earnings per share reached $2.77 versus $2.75 expected, with management spotlighting new 'event contracts' and booming retail sales in micro products to diversify revenue streams.
Announced $6.15 annual variable dividend plus $1.30 Q1 payout—totaling ~$4B for 2025 at 4.2% yield—while planning summer launch of single-stock futures on top names like NVIDIA and Tesla for capital-efficient exposure.

Sentiment:

🐃Bullish

Investment Analysis

Brookfield

BN

Pros

Brookfield Corp benefits from diversified, long-duration real asset exposure across infrastructure, renewables, real estate, and private equity, providing resilience to economic cycles.
The company’s global scale and presence in multiple high-growth geographies enable access to proprietary deal flow and sizeable investment opportunities not available to smaller competitors.
Strong institutional partnerships and substantial third-party capital under management generate recurring, high-margin asset management fees and reduce dependence on balance sheet leverage.

Considerations

Brookfield’s elevated leverage and debt-to-equity ratio increase sensitivity to rising interest rates and refinancing risks in volatile credit markets.
Complex corporate structure and multiple subsidiaries create challenges in transparency, governance, and consistent investor communication.
Exposure to illiquid, long-term real assets may result in valuation volatility and limited flexibility during periods of market stress or liquidity contraction.

CME Group

CME

Pros

CME Group operates the world’s largest and most liquid derivatives marketplace, with a near-monopoly position in key global benchmark products for interest rates, equity indices, commodities, and FX.
The business model is highly scalable and cash-generative, driven by high-margin electronic trading, recurring clearing revenues, and minimal operational leverage in a largely fixed-cost infrastructure.
Global regulatory emphasis on central clearing and risk management supports long-term structural growth in demand for CME’s core products and services.

Considerations

CME Group’s earnings are sensitive to trading volumes, which can fluctuate significantly with macro volatility, interest rate cycles, and investor risk appetite.
The company faces increasing competition from alternative trading venues, regional exchanges, and over-the-counter markets, which may erode pricing power over time.
Regulatory changes or shifts in clearing mandates could disrupt business flows, while market structure reforms may reduce the profitability of certain legacy products.

Related Market Insights

Complexity Kings: When Opacity Creates Opportunity

Discover Nemo's Complexity Kings Neme. Invest in companies with opaque structures and hidden value, poised for significant returns as economic pressures force simplification.

Aimee Silverwood | Financial Analyst

July 25, 2025

Read Insight

Related Market Insights

Complexity Kings: When Opacity Creates Opportunity

Discover Nemo's Complexity Kings Neme. Invest in companies with opaque structures and hidden value, poised for significant returns as economic pressures force simplification.

Aimee Silverwood | Financial Analyst

July 25, 2025

Read Insight

About The Companies

Brookfield (BN)

Brookfield Corporation (ticker: BN) is a large, diversified global asset manager focused on real assets — including real estate, infrastructure, renewable power and private equity — with a market cap of about $111.87 billion. The company combines ownership of operating businesses with an expanding fee-related earnings model: it earns investment returns from long‑term holdings and management fees from funds and third‑party capital. Investors often look to Brookfield for exposure to tangible assets and growing recurring revenue as its asset-management business scales. Key considerations include sensitivity to asset valuations, leverage levels, interest rates and the illiquid nature of many underlying investments. Brookfield’s size and global reach can offer diversification benefits, but performance can vary with economic cycles and commodity or rate movements. This summary is for general educational purposes only and is not personal financial advice; investors should assess suitability, risks and fees and consider seeking independent advice.

CME Group (CME)

CME Group Inc. (CME) operates some of the world’s largest futures and options markets — including the CME, CBOT, NYMEX and COMEX exchanges — and provides clearing, market data and trading technology. Its revenues are driven by trading volumes, open interest, clearing fees and data subscriptions, making performance sensitive to market volatility, interest rates and global economic activity. Strengths include scale, deep liquidity, recurring data and clearing revenues, strong cash generation and a large market footprint. Key risks include regulatory change, competition from other exchanges and trading venues, shifts in volatility or volumes, and operational or technology issues. With a market cap near $96.8bn, CME is often viewed as a core market-structure play rather than a cyclical commodity business. This is general information for educational purposes only, not personalised investment advice; values can rise and fall and past performance is not a reliable indicator of future returns.

Brookfield (BN) Next Earnings Date

BN (The Bank of New York Mellon Corporation) is expected to report its next earnings on April 15-16, 2026, covering the first quarter of 2026 (Q1 2026). This date aligns with analyst estimates and the company's historical mid-April reporting pattern for Q1 results. Investors should monitor official announcements for confirmation, as dates are subject to adjustment.

CME Group (CME) Next Earnings Date

CME Group's next earnings report is scheduled for April 28, 2026, covering the first quarter of 2026. The company typically releases earnings after market close on their announcement dates. Based on historical patterns, CME has consistently reported quarterly results with earnings per share expectations in the $2.50-$3.00 range. Investors should monitor this date for potential market volatility typical of earnings announcements.

Brookfield (BN) Next Earnings Date

BN (The Bank of New York Mellon Corporation) is expected to report its next earnings on April 15-16, 2026, covering the first quarter of 2026 (Q1 2026). This date aligns with analyst estimates and the company's historical mid-April reporting pattern for Q1 results. Investors should monitor official announcements for confirmation, as dates are subject to adjustment.

CME Group (CME) Next Earnings Date

CME Group's next earnings report is scheduled for April 28, 2026, covering the first quarter of 2026. The company typically releases earnings after market close on their announcement dates. Based on historical patterns, CME has consistently reported quarterly results with earnings per share expectations in the $2.50-$3.00 range. Investors should monitor this date for potential market volatility typical of earnings announcements.

Which Baskets Do They Appear In?

Complexity Kings

Navigate the maze of corporate complexity with this carefully curated collection. Our professional analysts have identified companies whose intricate structures and opaque financial reporting potentially hide significant value that the broader market may have missed.

Published: June 17, 2025

Explore Basket

Which Baskets Do They Appear In?

Complexity Kings

Navigate the maze of corporate complexity with this carefully curated collection. Our professional analysts have identified companies whose intricate structures and opaque financial reporting potentially hide significant value that the broader market may have missed.

Published: June 17, 2025

Explore Basket

Discover More Comparisons

Brookfield vs SMBC Group

Brookfield vs SMBC Group: comparing business models

Brookfield vs Chubb

Brookfield vs Chubb: a neutral comparison

Brookfield vs BMO

Brookfield vs BMO: A neutral comparison

Brookfield vs CME Group

Comparison Snapshot

Why It's Moving

Brookfield Shares Jump 2.8% as Earnings Beat Expectations with Dividend Hike and Massive Buyback.

CME Stock Warning Overstated: Record Highs and Earnings Beats Counter Analyst Downside Fears

Brookfield Shares Jump 2.8% as Earnings Beat Expectations with Dividend Hike and Massive Buyback.

CME Stock Warning Overstated: Record Highs and Earnings Beats Counter Analyst Downside Fears